WHY PHILANTHROPY MATTERS
This Is a Critical Moment for Parkinson's and DLB Research.
For decades, treatment has focused largely on managing symptoms. Today, that is beginning to change. Researchers are uncovering the biology that drives Parkinson's disease and dementia with Lewy bodies, identifying disease earlier, and developing therapies designed to slow or stop progression.
We are closer than ever to turning these advances into disease-modifying treatments- but this is exactly the stage where momentum matters most.
Accelerate What- Is Ready
Strong scientific ideas, promising preliminary findings, and new technologies are already available. Philanthropic funding can help us move quickly from discovery to the next decisive experiment—without losing valuable time.
Bridge the Critical Gap
Some of the most important projects sit between an exciting discovery and the larger studies needed to bring it toward patients. Flexible support allows us to generate the evidence required to cross that gap.
Build the Capacity to Go Further
Progress depends not only on individual experiments, but on researchers, technologies, patient cohorts, and international collaborations. Philanthropy allows us to strengthen this research infrastructure now—so that promising ideas can move faster and further.
“The opportunity is here. The science is advancing.
What we need now is the support to turn momentum into therapies that can truly change the course of disease.”
Your support today can help shorten
the distance between scientific discovery and a treatment that changes patients' lives.
Partnering for Scientific Progress.
We believe scientific progress moves faster when the right partners, questions, and expertise come together. American Friends of ParkinsonFonds Deutschland helps shape focused research projects and connects support to work with a clear scientific purpose.
This allows our partners to support specific research questions and defined projects - not just a broad field.
